We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Semisynthesis of homogeneous spike RBD glycoforms from SARS-CoV-2 for profiling the correlations between glycan composition and function.
- Authors
Ye, Farong; Li, Cheng; Liu, Feng-Liang; Liu, Xinliang; Xu, Peng; Luo, Rong-Hua; Song, Wenping; Zheng, Yong-Tang; Ying, Tianlei; Yu, Biao; Wang, Ping
- Abstract
Vaccines have been the primary remedy in the global fight against coronavirus disease 2019 (COVID-19). The receptor-binding domain (RBD) of the spike protein, a critical viral immunogen, is affected by the heterogeneity of its glycan structures and relatively low immunogenicity. Here, we describe a scalable synthetic platform that enables the precise synthesis of homogeneously glycosylated RBD, facilitating the elucidation of carbohydrate structure–function relationships. Five homogeneously glycosylated RBDs bearing biantennary glycans were prepared, three of which were conjugated to T-helper epitope (Tpep) from tetanus toxoid to improve their weak immune response. Relative to natural HEK293-derived RBD, synthetic RBDs with biantennary N -glycan elicited a higher level of neutralising antibodies against SARS-CoV-2 in mice. Furthermore, RBDs containing Tpep elicited significant immune responses in transgenic mice expressing human angiotensin-converting enzyme 2. Our collective data suggest that trimming the N -glycans and Tpep conjugation of RBD could potentially serve as an effective strategy for developing subunit vaccines providing efficient protection.
- Subjects
GLYCANS; COVID-19; SARS-CoV-2; GLYCAN structure; ANGIOTENSIN converting enzyme; TETANUS vaccines
- Publication
National Science Review, 2024, Vol 11, Issue 2, p1
- ISSN
2095-5138
- Publication type
Article
- DOI
10.1093/nsr/nwae030